Development of potent, allosteric dual Akt1 and Akt2 inhibitors with improved physical properties and cell activity

This letter describes the development of potent, allosteric dual Akt1 and Akt2 inhibitors with improved aqueous solubility (∼18 mg/mL) that translates into enhanced cell activity and caspase-3 induction.

Figure optionsDownload as PowerPoint slide